California-based Brightseed has announced an expansion of its innovation programs for partners. Through the introduction of Rapid Profiling and the company’s newly expanded Microbiome capabilities, Brightseed is unlocking novel health insights for product development and accelerating commercialization timelines for food, nutrition and bioscience companies, the company stated. Brightseed will be presenting the company’s latest AI benchmarks, capabilities and research at the IPA World Congress + Probiota Americas 2024 conference in Salt Lake City, UT on June 12.
Brightseed’s expanded Microbiome discovery programs include the identification of microbially-derived bioactives and their associated health benefits when fermented ingredients or other prebiotic material interact with gut bacteria. Brightseed is collecting and analyzing fermented sources from around the globe with the help of global industry partners such as Korean food powerhouse, CJ Foods, to launch this effort.
“Our microbiome programs, which also include synbiotic product development, are tailored for companies who are deeply vested in bringing novel and clinically validated products into their food and consumer health portfolios,” said David Brown, vice president of business development at Brightseed. “The global market size for probiotics is valued at $58 billion, and synbiotics provide more robust benefits to consumers than probiotics alone. Forager allows us to predict bioactives resulting from the interaction between bacterial strains and natural ingredients, which is an exciting application of AI in microbiome research and innovation.”
At the annual IPA World Congress + Probiota Americas conference, Brightseed will present “How AI is Decoding the Microbiome” in the Tech Advances session on June 12. In addition, new research on Bio Gut Fiber’s impact on the microbiome will be presented in a poster session at the 2024 American Society of Microbiology (ASM) Microbe Conference in Atlanta, GA on June 14. The poster, titled “Novel plant-derived bioactive compounds shape the human gut microbiome in vitro,” (HMB-FRIDAY-9700) will be presented by Dr. Steven Frese and Karla Flores Martinez from the University of Nevada, Reno’s College of Agriculture, Biotechnology & Natural Resources.
For more information, visit www.brightseedbio.com.
